Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $19.74 billion. The enterprise value is $15.77 billion.
| Market Cap | 19.74B |
| Enterprise Value | 15.77B |
Important Dates
The last earnings date was Tuesday, April 28, 2026, before market open.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 199.78 million shares outstanding. The number of shares has decreased by -0.21% in one year.
| Current Share Class | 199.78M |
| Shares Outstanding | 199.78M |
| Shares Change (YoY) | -0.21% |
| Shares Change (QoQ) | +1.01% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | 87.68% |
| Float | 167.27M |
Valuation Ratios
The trailing PE ratio is 14.00 and the forward PE ratio is 12.46. Incyte's PEG ratio is 1.01.
| PE Ratio | 14.00 |
| Forward PE | 12.46 |
| PS Ratio | 3.68 |
| Forward PS | 3.38 |
| PB Ratio | 3.51 |
| P/TBV Ratio | 3.67 |
| P/FCF Ratio | 13.61 |
| P/OCF Ratio | 13.02 |
| PEG Ratio | 1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.18, with an EV/FCF ratio of 10.87.
| EV / Earnings | 11.01 |
| EV / Sales | 2.94 |
| EV / EBITDA | 10.18 |
| EV / EBIT | 10.84 |
| EV / FCF | 10.87 |
Financial Position
The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.68 |
| Quick Ratio | 3.40 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.03 |
| Interest Coverage | 622.25 |
Financial Efficiency
Return on equity (ROE) is 30.82% and return on invested capital (ROIC) is 71.39%.
| Return on Equity (ROE) | 30.82% |
| Return on Assets (ROA) | 13.89% |
| Return on Invested Capital (ROIC) | 71.39% |
| Return on Capital Employed (ROCE) | 24.86% |
| Weighted Average Cost of Capital (WACC) | 8.62% |
| Revenue Per Employee | $1.89M |
| Profits Per Employee | $503,438 |
| Employee Count | 2,844 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 28.20 |
Taxes
In the past 12 months, Incyte has paid $342.08 million in taxes.
| Income Tax | 342.08M |
| Effective Tax Rate | 19.28% |
Stock Price Statistics
The stock price has increased by +62.40% in the last 52 weeks. The beta is 0.80, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +62.40% |
| 50-Day Moving Average | 95.46 |
| 200-Day Moving Average | 94.66 |
| Relative Strength Index (RSI) | 54.61 |
| Average Volume (20 Days) | 1,448,683 |
Short Selling Information
The latest short interest is 11.97 million, so 5.99% of the outstanding shares have been sold short.
| Short Interest | 11.97M |
| Short Previous Month | 11.44M |
| Short % of Shares Out | 5.99% |
| Short % of Float | 7.16% |
| Short Ratio (days to cover) | 7.92 |
Income Statement
In the last 12 months, Incyte had revenue of $5.36 billion and earned $1.43 billion in profits. Earnings per share was $7.06.
| Revenue | 5.36B |
| Gross Profit | 2.83B |
| Operating Income | 1.45B |
| Pretax Income | 1.77B |
| Net Income | 1.43B |
| EBITDA | 1.55B |
| EBIT | 1.45B |
| Earnings Per Share (EPS) | $7.06 |
Balance Sheet
The company has $4.02 billion in cash and $39.43 million in debt, with a net cash position of $3.98 billion or $19.90 per share.
| Cash & Cash Equivalents | 4.02B |
| Total Debt | 39.43M |
| Net Cash | 3.98B |
| Net Cash Per Share | $19.90 |
| Equity (Book Value) | 5.62B |
| Book Value Per Share | 28.12 |
| Working Capital | 3.99B |
Cash Flow
In the last 12 months, operating cash flow was $1.52 billion and capital expenditures -$65.90 million, giving a free cash flow of $1.45 billion.
| Operating Cash Flow | 1.52B |
| Capital Expenditures | -65.90M |
| Depreciation & Amortization | 94.73M |
| Net Borrowing | -4.64M |
| Free Cash Flow | 1.45B |
| FCF Per Share | $7.26 |
Margins
Gross margin is 52.77%, with operating and profit margins of 27.13% and 26.71%.
| Gross Margin | 52.77% |
| Operating Margin | 27.13% |
| Pretax Margin | 33.09% |
| Profit Margin | 26.71% |
| EBITDA Margin | 28.89% |
| EBIT Margin | 27.13% |
| FCF Margin | 27.06% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.21% |
| Shareholder Yield | 0.21% |
| Earnings Yield | 7.25% |
| FCF Yield | 7.35% |
Analyst Forecast
The average price target for Incyte is $103.52, which is 4.76% higher than the current price. The consensus rating is "Buy".
| Price Target | $103.52 |
| Price Target Difference | 4.76% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (5Y) | 2.54% |
| EPS Growth Forecast (5Y) | 4.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 7.94 and a Piotroski F-Score of 7.
| Altman Z-Score | 7.94 |
| Piotroski F-Score | 7 |